Evaluation of epratuzumab as a biologic therapy in systemic lupus erythematosus

THU0277 Epratuzumab: Sustained Safety Profile and Effect on Corticosteroid Use on Long-Term Treatment in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)

(2014) D. J. Wallace et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

(2013) Daniel J Wallace et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study

(2013) Eduardo F. Mysler et al.   ARTHRITIS AND RHEUMATISM

B-Cell Targeted Therapies in Systemic Lupus Erythematosus

(2013) Philip R. Harvey et al.   BIODRUGS

New biologic therapy for systemic lupus erythematosus

(2013) Hui Jen Ding et al.   CURRENT OPINION IN PHARMACOLOGY

Diagnostic criteria for systemic lupus erythematosus: has the time come?

(2013) George K. Bertsias et al.   Nature Reviews Rheumatology

Effect of gender on clinical presentation in systemic lupus erythematosus

(2013) G. Murphy et al.   RHEUMATOLOGY

Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up

(2013) Daniel J. Wallace et al.   RHEUMATOLOGY

Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006

(2013) V. Strand et al.   RHEUMATOLOGY

Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study

(2013) M Compagno et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

The Incidence and Prevalence of Systemic Lupus Erythematosus, 2002-2004: The Georgia Lupus Registry

(2013) S. Sam Lim et al.   Arthritis & Rheumatology

Population-Based Incidence and Prevalence of Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program

(2013) Emily C. Somers et al.   Arthritis & Rheumatology

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

CD22 ligation inhibits downstream B cell receptor signaling and Ca2+flux upon activation

(2012) N. Sieger et al.   ARTHRITIS AND RHEUMATISM

Emerging and critical issues in the pathogenesis of lupus

(2012) Mariele Gatto et al.   AUTOIMMUNITY REVIEWS

The pathogenesis of systemic lupus erythematosus—an update

(2012) Jinyoung Choi et al.   CURRENT OPINION IN IMMUNOLOGY

CD22 and Autoimmune Disease

(2012) Thomas Dörner et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis

(2012) Marc Weidenbusch et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

The antinuclear antibody assay: developing criteria for reflexive anti-dsDNA antibody testing in a laboratory setting

(2011) Wendy Y. Craig et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

ANA screening: an old test with new recommendations

(2010) P. L. Meroni et al.   ANNALS OF THE RHEUMATIC DISEASES

Systemic lupus erythematosus: Clinical presentations

(2010) Paul P. Smith et al.   AUTOIMMUNITY REVIEWS

Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus

(2010) J. Nossent et al.   LUPUS

Contemporary treatment of systemic lupus erythematosus: an update for clinicians

(2010) Maame B. Amissah-Arthur et al.   Therapeutic Advances in Chronic Disease

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Systemic Lupus Erythematosus

(2008) Anisur Rahman et al.   NEW ENGLAND JOURNAL OF MEDICINE